The Pirbright Institute is to play a key role in a new international project funded by the European Commission, to fight the mosquito-transmitted diseases now threatening Europe.
The Infravec2 Project is an international consortium of 24 partner institutions coordinated by the Institut Pasteur, Paris.
A student studying for his PhD at The Pirbright Institute was named Young Innovator of the Year at the Guildford Innovation Awards 2017 on 22 February 2017. Tom Whitehead won the award for his research on egg anti-viral proteins which could lead to a major step forward in vaccine production rates.
The American Association for the Advancement of Science (AAAS) has selected a senior scientist at The Pirbright Institute as a 2017-2018 AAAS Alan I. Leshner Leadership Institute Public Engagement Fellow.
® The Pirbright Institute 2022 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
